Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Century Therapeutics, Inc. (IPSC) had Cash Flow from Financial Activities of $126.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-21.64M |
|
-- |
|
-- |
|
$23.68M |
|
$-23.68M |
|
$2.04M |
|
$-21.64M |
|
$-21.64M |
|
$-21.64M |
|
$-21.64M |
|
$-21.64M |
|
$-21.64M |
|
$-23.68M |
|
$-20.89M |
|
193.47M |
|
193.47M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$139.04M |
|
$47.61M |
|
$187.51M |
|
$326.55M |
|
$13.57M |
|
-- |
|
$48.24M |
|
$61.81M |
|
$264.74M |
|
$230.54M |
|
$264.74M |
|
87.52M |
|
| Cash Flow Statement Financials | |
$-25.26M |
|
$-112.61M |
|
|
Cash Flow from Financial Activities |
$126.62M |
$65.01M |
|
$53.76M |
|
$-11.25M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.18% |
|
-9.39% |
|
-6.63% |
|
-8.18% |
|
$3.02 |
|
$-0.13 |
|
$-0.13 |
|